Zobrazeno 1 - 10
of 660
pro vyhledávání: '"T. Miyagawa"'
Autor:
K. Oka, T. Miyagawa, H. Suga, S. Shibata, T. Miyagaki, H. Kamijo, Y. Mizuno, T. Hisamoto, I. Omori, H. Boki, N. Takahashi-Shishido, M. Sugaya, S. Sato
Publikováno v:
Journal of Investigative Dermatology. 143:S42
Publikováno v:
Journal of Investigative Dermatology. 143:S78
Autor:
T. Miyagawa
Publikováno v:
Concrete Journal. 58:328-333
Autor:
K. Oka, T. Miyagawa, H. Suga, T. Miyagaki, Y. Mizuno, T. Hisamoto, I. Omori, H. Boki, N. Takahashi-Shishido, S. Sato
Publikováno v:
Journal of Investigative Dermatology. 142:S262
Autor:
R. Kizawa, M. Kuno, S. Washino, S. Shirotake, K. Izumi, M. Inoue, M. Kagawa, H. Takeshita, Y. Hyodo, S. Kawakami, K. Saito, Y. Kageyama, M. Oyama, T. Miyagawa, Y. Miura
Publikováno v:
Annals of Oncology. 33:S1488
Autor:
T. Nakayama, H. Takeshita, M. Kagawa, S. Washino, S. Shirotake, Y. Miura, Y. Hyodo, K. Izumi, M. Inoue, T. Miyagawa, M. Oyama, K. Saito, Y. Kageyama, S. Kawakami
Publikováno v:
Annals of Oncology. 33:S1487
Autor:
T. Miyagawa
Publikováno v:
Concrete Journal. 57:302-306
Autor:
Y. Iwata, K. Satou, H. Tsuzuku, K. Furuichi, Y. Senda, Y. Sakai-Takemori, T. Wada, S. Fujita, T. Miyake, H. Yasuda, N. Sakai, S. Kitajima, T. Toyama, Y. Shinozaki, A. Sagara, T. Miyagawa, A. Hara, M. Shimizu, Y. Kamikawa, S. Kaneko
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 36:1839-1845
Daptomycin (DAP) is widely used in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection. The emergence of DAP non-susceptible MRSA strains during therapy is a major concern in clinical settings. Recent studies revealed that M
Publikováno v:
EMBC
Nanopore-based diagnostic systems are a promising tool for counting viruses in a specimen one by one. However, despite intensive RD efforts, it remains difficult to recognize virus subtypes by nanopore devices. We thus propose a novel diagnostic syst
Autor:
M. Tsuchikawa, Jan Tack, Gediminas Urbonas, Ivan Bunganic, Hans Törnblom, V. Yakusevich, T. Miyagawa, C. Banciu, Juris Pokrotnieks, P. Eavis, Y. Kleban
BACKGROUNDS: Acotiamide is a novel acetylcholinesterase inhibitor for treatment of postprandial distress syndrome (PDS) symptoms of functional dyspepsia (FD). This European phase 3 open-label safety trial has been conducted to evaluate the long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::161c21d814c571f4bd531d26bc8f1fc6
https://lirias.kuleuven.be/handle/123456789/642205
https://lirias.kuleuven.be/handle/123456789/642205